Urinary Tract Infection Testing Market to Reach $1 Billion, Globally, by 2031 at 6.2% CAGR: Allied Market Research

News provided by

Feb 04, 2023, 02:30 ET

Increase in prevalence of urinary tract infections, a rising geriatric population, and rapid technological advancements drive the global urinary tract infection testing market. By test kit, the laboratory test kits segment would lead the market in 2031.

PORTLAND, Ore., Feb. 4, 2023 /PRNewswire/ -- Allied Market Research published a report, titled, "Urinary Tract Infection Testing Market by Infection Type (Urethritis, Cystitis, Pyelonephritis), by Test Type (Urinalysis , Urine Cultures, Susceptibility Testing), by End User (Hospitals, Diagnostic Laboratories, Research Institutes), by Test Kit (Home Test Kits, Laboratory Test Kits): Global Opportunity Analysis and Industry Forecast, 2021- 2031" According to the report, the global urinary tract infection testing industry is estimated to generate $574 million in 2021 and $1 billion by 2031, witnessing a CAGR of 6.2% from 2022 to 2031. The report offers a detailed analysis of changing market trends, top segments, key investment pockets, value chain, regional landscape, and competitive scenario.

Download Free Sample Report: https://www.alliedmarketresearch.com/request-sample/31812

Drivers, Restraints, and Opportunities

Increase in prevalence of urinary tract infections, a rising geriatric population, and rapid technological advancements fuel the growth of the global urinary tract infection testing market. However, errors such as false negative or false positive results in UTI testing may hinder the global market growth. On the other hand, the availability self-testing kits for UTI testing and the increasing prevalence of diabetes globally will present new growth opportunities for the global urinary tract infection testing market in the coming years.

Covid-19 Scenario

The COVID-19 pandemic moderately impacted the urinary tract infection testing market across the globe in the initial period of the pandemic on account of low hospitalization.
Stringent lockdowns imposed by government across the world had a significant impact on the number of UTI tests conducted. Moreover, supply chain constraints, jammed logistics due to lockdowns, and other regulatory restrictions hampered the market growth.
The market has recovered post the pandemic.

The laboratory test kits segment to dominate during the forecast period

Based on test kit, the laboratory test kits segment contributed to the largest share of three-fourths of the global urinary tract infection testing market in 2021, and is expected to maintain its leadership during the forecast period. Moreover, the same segment is projected to witness the fastest CAGR of 6.3% from 2022 to 2031. This is because laboratory test kits can produce accurate test results on a smartphone. In addition, patients can check if they are infection-free or not just by using laboratory UTI test kits.

The cystitis segment to maintain a prominent revenue growth in 2031

Based on infection type, the cystitis segment held the largest share of more than half of the global urinary tract infection testing market in 2021, and is expected to maintain a prominent growth during the forecast period. Every year, around 10 out of every 100 women globally are diagnosed with cystitis. However, the pyelonephritis segment is expected to exhibit the highest CAGR of 6.5% in 2031, as pyelonephritis is one of the most commonly occurring diseases of the kidney.

Purchase Inquiry: https://www.alliedmarketresearch.com/purchase-enquiry/31812

The urinalysis segment to achieve a noteworthy growth during the forecast period

Based on test type, the urinalysis segment held the largest share of more than two-fifths of the global urinary tract infection testing market in 2021 and is expected to dominate the market in 2031. The same segment is expected to exhibit the highest CAGR of 6.7% in 2031, owing to increased demand for the diagnosis of urinary tract infections, kidney issues, and diabetes from healthcare providers.

The hospitals segment to garner the largest revenue during the forecast period

Based on end user, the hospitals segment held the largest share of nearly half of the global urinary tract infection testing market in 2021 and is expected to lead the trail in 2031. This is owing to a rise in instances of hospital-acquired urinary tract infection. However, the diagnostic laboratories segment is expected to exhibit the highest CAGR of 6.8% in 2031. Laboratory diagnosis is based on colony counts following culture which reflect the concentration of organisms in urine.

North America to garner the largest revenue by 2031

Based on region, the market in North America was the largest in 2021, accounting for two-fifths of the global urinary tract infection testing market, owing to the presence of major players and high spending on healthcare in this region. However, the market in Asia-Pacific is likely to dominate in terms of revenue and show the fastest CAGR of 7.4% during the forecast period, due to the increasing geriatric population in this region.

Leading Market Players

Thermo Fisher Scientific, Inc.
Bio-Rad Laboratories
Danaher Corporation
ACON Laboratories Inc.
Cardinal Health Inc.
Stryker Corporation
SYSMEX CORPORATION
Abbott Laboratories
Roche AG
LabCorp (Laboratory Corporation of America Holdings)

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Urinary Tract Cancer Market by Cancer type (Bladder Cancer, Urethral cancer and Ureteric and Renal Pelvic Cancer), Treatment Type (Chemotherapy, and Immunotherapy), and Distribution Channel (Retail Pharmacy, and Online Pharmacy): Global Opportunity Analysis and Industry Forecast, 2021--2030

Telemedicine Market by Application (Teleradiology, Telepsychiatry, Telepathology, Teledermatology, Telecardiology and Other Applications), Component (Software, Hardware and Services), and End User (Healthcare Providers, Payers, Healthcare Consumers and Other End Users): Global Opportunity Analysis and Industry Forecast, 2021-2030

Allergy Diagnostics Market by Test Type (In Vivo, In Vitro), by Product & Service (Consumables, Instruments, Services), by Allergen (Inhaled Allergens, Food Allergens, Drug Allergens, Other Allergens), by End-user (Diagnostic Laboratories, Hospital-based Laboratories, Academic Research Institutes, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

Plasma Fractionation Market by Product (Albumin, Immunoglobulins, Coagulation factor VIII, and Coagulation factor IX) and Sector (Public Sector and Private Sector): Global Opportunity Analysis and Industry Forecast, 2020-2027

Digital Therapeutics Market by Product (Software and Devices), Sales Channel (Business-to-Business and Business-to-Consumers), Application (Diabetes, Obesity, Cardiovascular Disease (CVD), Central Nervous System (CNS), Disease Respiratory Disease, Smoking Cessation, Gastrointestinal Disorder (GID) and Others: Global Opportunity Analysis and Industry Forecast, 2022-2031

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
[email protected]